| Tag | Content |
|---|
EnhancerAtlas ID | HS187-16923 |
Organism | Homo sapiens |
Tissue/cell | Th1 |
Coordinate | chr3:36953330-36955070 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| ESR1 | MA0112.3 | chr3:36953699-36953716 | AAGGTCAGCGTGACTCT | - | 6.23 | | ESR2 | MA0258.2 | chr3:36953700-36953715 | AGGTCAGCGTGACTC | + | 6.21 | | FOXP2 | MA0593.1 | chr3:36954353-36954364 | TTTGTTTACTT | - | 6.62 | | IRF1 | MA0050.2 | chr3:36953936-36953957 | CTGCACTTTCAGTTTCGTTAA | + | 6.49 | | IRF8 | MA0652.1 | chr3:36953940-36953954 | ACTTTCAGTTTCGT | - | 6.79 | | IRF9 | MA0653.1 | chr3:36953940-36953955 | ACTTTCAGTTTCGTT | - | 7.56 | | POU2F2 | MA0507.1 | chr3:36954109-36954122 | AAATGCAAATGCA | - | 6.16 | | ZNF263 | MA0528.1 | chr3:36954949-36954970 | TCCTCTCCTCTCCTCTCCTCT | - | 6.37 | | ZNF263 | MA0528.1 | chr3:36954954-36954975 | TCCTCTCCTCTCCTCTCCTCT | - | 6.37 |
|
| | Number of super-enhancer constituents: 11 | ID | Coordinate | Tissue/cell |
| SE_10772 | chr3:36953030-36955433 | CD19_Primary | | SE_11103 | chr3:36952240-36956115 | CD20 | | SE_13757 | chr3:36952418-36955708 | CD34_Primary_RO01536 | | SE_14670 | chr3:36952526-36955912 | CD4_Memory_Primary_7pool | | SE_20546 | chr3:36952863-36955404 | CD56 | | SE_20995 | chr3:36952572-36955944 | CD8_Memory_7pool | | SE_22848 | chr3:36952447-36954974 | CD8_primiary | | SE_58613 | chr3:36917116-36975497 | Ly1 | | SE_60302 | chr3:36931480-36967184 | Ly4 | | SE_62039 | chr3:36916419-36960640 | Toledo | | SE_62698 | chr3:36917032-36967259 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr3 | 36953847 | 36954333 | | chr3 | 36953378 | 36953438 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH03I036911 | chr3 | 36952606 | 36955254 |
|
Enhancer Sequence | ATATCTGCTA AGTACCTACT ATGTGCTTTA CATCATTGTG TCTTTTCATT CTTATAAGAA 60
GCCTCGGCCA GGCACAGTGG CTCACGCCTG TAAACCCAAC ATTTTGGGAG GCCGAAGCAG 120
GCAGATTAGC TGAGGTCAGG AGTTCGAGAC CAGCCTGGCC AACATGGTGA AACCCCCATC 180
TCTACTAAAA ATATACAAAA ATTAGCCAGG CATGGTAGTG CATGCCTATA GCCCCAGCTA 240
CTCAGGAAGC TGAGGCACGA GAATCACTTA AGCCCAGGAG ATGCAGGTTG TAGTGAGCTG 300
AGATCAAGCC ACTGCATTCC AGCCTGGGCA ACAGAGTGAG ACTCTGTCAA AAAAAAAAAA 360
AAGTGCTATA AGGTCAGCGT GACTCTATCT CTATTTTGCA CATAAGGAAA GTGAAGCAAA 420
GACAGGTTAA GCCACTTACC ACTTGCCACA GTCACACTGA AATTGGTAAT GTGAGAATTC 480
CAACCTAGGT GGCCTCACTT TAAGAGCCAA ACTACACTCT GAAGGGCCAA GACAGAGGCT 540
AAAAGATCAG CACCCAGTAA AATCACTAGG GTATCTTATA TTTTGGCTGG CACTGAGCAC 600
TCTACCCTGC ACTTTCAGTT TCGTTAATGG TGTAAAAGCT ACAAAATACT TAAGGACAAT 660
TGCACAGCTG CCTGGCTGGC TTTCAGAAAT TTTCACTATG TCTCTATGAG AATTCAAACT 720
CTAGTTGTTG GAAGCTGTCA CAGGCTGCTG AGCTACATAT GAGGAAGAAG ATGCAAGAAA 780
AATGCAAATG CACTGAGTAG ATTTTGAAAC AAGCAAGTCT GAAACAGAGC AGATCCAGGT 840
GGTTGTGGGT TTTATGACTC ATTGTGTATA CGTATACACA TGAAGTTCTG TAACTGACAT 900
ACAGGATTAC AGCAAAGACT GGCAACACAG ATGGCCTATG GAGGGGTTAT TACTGAAATG 960
GGCAGAGAGG ATGGCTTTCC CTTCATACAT TATCTGGGTA CTGCTTGAAT TCTTGACAAC 1020
AAATTTGTTT ACTTTTTTAT TTTATTTTTT TGGGGTTTTT TGTTTGCTTG CTTGCTTTTT 1080
TTGTTTAGGG TTGCCAAAAG AGCCCAAAAG CAGTCAATGA TCCAAGATTA ACTCGGGAAT 1140
GCTGGCAGTA GCAGTAGATC CAAGTTGAAG CTAGAAAGAG TATGTCTCTT TTGTGTGTGT 1200
GTGTGTGTGT GTGTGTGTGT GTGATGGAGT CTCACTCTGT CACCCAGGCT GGAGTGCAGT 1260
GGCGCAATCT TGGCTCACTG CAACCTCCAT CTCTCGAATT CAAGCCATTC TCCTGCTTCA 1320
GCTTCCTGAG TAGCTGGGAT TACAGGCGTG CGCCCTGTAA TCCCACCATG CCCAGCTAAC 1380
TTTCTATATT TAGTAGAAAT AGGGTTTCCC CATGTTGGCC AGACTGGTCT CGAACTCCTG 1440
ACCTCAAGTG ATCCGGCCGC CTCGTGTCCC AAAGTGCTGG GATTACAGGC TTGAGCCACC 1500
ATGACCGTCC TTTTCCTTCT ATCTTTCTAT CTATCTTTCT TTCTTGCCTG TTTGCTTGCT 1560
TGCTTGCTTG CTTGCTCACT TACTTTCTTG CTTGCTTTCT TTTTCTTGCT TTGTTTCTCT 1620
CCTCTCCTCT CCTCTCCTCT CCTCTCTTTC TTTCTCTCCT CTCCTCTCCT CTCTTTCTTT 1680
CTCTCTCTCT TAAAAGTGAC TCTTTCCTCT TCCCCGCAGG AAGGGTGCCA CAGACAGTCA 1740
|
